It’s that time of the year; We all likely indulged more than we’d like to admit for the holidays and put on a few extra pounds. While exerci...

By Meg Tirrell, CNN(CNN) — Since Ozempic blasted onto the stage in 2017 with its approval for type 2 diabetes, drugmakers Novo Nordisk an...

WASHINGTON (AP) — Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and...

Ann Lewandowski knows all about pharmacy benefit managers, or PBMs, the companies that shape the U.S. drug market. Her job, as a policy advo...

By Madison Muller, Bloomberg News (TNS)For the first time in a decade, obesity in the US is declining — and a new study suggests it’s becau...

Michael Merschel | (TNS) American Heart Association NewsWhen you hear a favorite holiday tune, you might not immediately connect it with CP...

Some patients taking weight-loss drugs, including popular GLP-1 treatments like Ozempic (NVO) and Wegovy, reported reducing their consumptio...

Sales of antiobesity drugs hit $1.1 billion in the second quarter of 2023.

Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables.

With more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more effective?I...

Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped pat...

Zepbound is the “superior” choice for people looking to shed a few pounds, at least compared to Novo Nordisk’s (NVO) Wegovy, according to El...

By Deidre McPhillips, CNN(CNN) — Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical...

Novo Nordisk, the Danish company that makes diabetes drug Ozempic and obesity treatment Wegovy, has begun work on a 5.3ha quality control ce...

You may have heard about GLP-1 which is the hormone at the heart of weight loss medications like Ozempic, Wegovy and Mounjaro.These medicat...